University of Chicago
Chicago, Illinois, 60637, United States
NCT Number: NCT02653066
The purpose of this research is to study the utility of using the HealtheRx as a tool to recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the University of Chicago. HealtheRx is an example of a potential recruitment tool that has high reach in populations typically underrepresented in research studies, uses a high tech infrastructure that allows matching of research opportunities to patient characteristics, but that delivers information in a low-tech, patient-centered mode using the printed HealtheRx prescription.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60637, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Participant receives $5 bill with incentive check and blank consent form
Participant receives $5 bill when they returned signed PRR consent form.
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
University of Chicago
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06461403
Acute Exacerbation of COPD, Asthma
Chicago, Illinois, United States
View Trial DetailsNCT00793676
Asthma, Bronchial Diseases
Colmar, France
View Trial DetailsNCT05803902
Asthma, Atopic Dermatitis
Beijing, Beijing Municipality, China
View Trial Details